Quantcast

Latest Heart failure Stories

2014-02-26 16:28:47

FRAMINGHAM, Mass., Feb. 26, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Raymond James 35(th) Annual Institutional Investors Conference at 4:35 p.m. EST on Tuesday, March 4, 2014. The conference is being held March 2-5 at JW Marriott Grande...

2014-02-25 08:32:27

Cardioxyl now evaluating clinical safety and tolerability of improved second-generation HNO prodrug targeting acute decompensated heart failure CHAPEL HILL, N.C., Feb. 25, 2014 /PRNewswire/ -- Cardioxyl Pharmaceuticals, Inc. announced today that the first cohort of patients has been dosed in a Phase I clinical trial of CXL-1427, a novel nitroxyl (HNO) prodrug optimized for clinical development as a potential treatment for acute decompensated heart failure (ADHF). The primary...

2014-02-25 08:32:22

Online Information Helps Consumers Compare Hospital Quality of Care and Prevent Heart Disease RICHMOND, Va., Feb. 25, 2014 /PRNewswire-USNewswire/ -- In celebration of American Heart Month, Virginia Health Information (VHI) has published its Cardiac Care Report. The report lets consumers compare rates of mortality for cardiac patients in Virginia hospitals, 30-day hospital readmissions and how often hospitals provide a variety of cardiac care services. VHI's Cardiac Care Report is a free,...

2014-02-25 08:31:18

Both Needed the SynCardia Total Artificial Heart to Save Their Lives & Help Make Them Stronger for Their Donor Heart Transplants TUCSON, Ariz., Feb. 25, 2014 /PRNewswire/ -- A Newport News, Va., mom and her adult son each had heart problems that started in their early 30s, resulting in the need to receive donor heart transplants in order to live. Because time was of the essence and no donor hearts were available, they each had SynCardia temporary Total Artificial Heart implants to...

2014-02-19 16:24:19

Big Data Solution Identifies 8,500 Patients at Risk for Heart Failure Using Insights from Electronic Medical Records ARMONK, N.Y., Feb. 19, 2014 /PRNewswire/ -- IBM (NYSE: IBM) today announced that Virginia health system Carilion Clinic has identified 8,500 patients at risk for developing heart failure in a pilot project that could lead to early intervention and better care for these patients. (Logo: http://photos.prnewswire.com/prnh/20090416/IBMLOGO ) The pilot was completed in...

2014-02-19 12:28:22

Sets Stage for Expanded Adoption Of CARILLON® Mitral Contour System® KIRKLAND, Wash., Feb. 19, 2014 /PRNewswire/ -- Cardiac Dimensions(®),( )Inc. today announced that the Company's CARILLON(® )Mitral Contour System(® )has received German Neue Untersuchungs und Behandlungsmethoden (NUB) Status 1 approval across 120 leading hospitals in Germany, a decision from German regulators that may positively influence reimbursement from insurance companies for the costs of CARILLON...

2014-02-19 11:02:44

Using multidisciplinary approach, researchers in Italy and Connecticut provide unprecedented glimpse of what happens to the heart during a heart attack A team of researchers at the University of Florence in Italy and the University of Connecticut Health Center have used a multidisciplinary approach to provide an unprecedented glimpse of what happens to the heart during an "infarction" -- a heart attack -- by looking at how the attack affects electrical activity and calcium release in heart...

2014-02-18 12:31:14

The Freedom Driver Won Edison's 2013 Silver Award for Its Ability to Allow Stable Total Artificial Heart Patients to Live Life at Home Without Human Hearts TUCSON, Ariz., Feb. 18, 2014 /PRNewswire/ -- The Freedom® portable driver that powers the SynCardia temporary Total Artificial Heart, the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, has been named one of four finalists for the 2014 Edison Awards' devices section in the...

2014-02-18 08:31:03

- Statistically significant and durable reductions in troponin and NT-proBNP SAN DIEGO, Feb. 18, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today announced new data from its randomized, placebo-controlled, nonclinical study of MST-188 (low dose and high dose) in a model of chronic heart failure. The Company previously announced that a single, two-hour infusion of MST-188 improved left ventricular systolic function that was significant immediately (at the end of MST-188...

2014-02-12 23:04:01

AAHFN Encourages Patient Education to Help Avoid Early Readmission Mount Laurel, NJ (PRWEB) February 12, 2014 The American Association of Heart Failure Nurses (AAHFN) is reminding healthcare providers to take the time to teach patients and promote healthy lifestyles to individuals living with heart failure, in order to avoid early hospital readmission. The year-long campaign that encourages patients to “keep your heart at home” kicked off earlier this week, in honor of Heart Failure...


Latest Heart failure Reference Libraries

Circulation (journal)
2012-06-04 14:21:01

Circulation is a scientific journal published by Lippincott Williams & Wilkins on behalf of the American Heart Association. In 2008 the journal added six subspecialty publications: Circulation: Arrhythmia and Electrophysiology, Circulation: Heart Failure, Circulation: Cardiovascular Imaging, Circulation: Cardiovascular Interventions, Circulation: Cardiovascular Quality and Outcomes, and Circulation: Cardiovascular Genetics. Circulation publishes articles related to research in and the...

More Articles (1 articles) »
Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.